본문 바로가기
KERD
논문KCI 등재

Scopolamine 유발 기억력손상 흰 쥐에서 笭桂甘棗湯加龍骨牡蠣의 인지기능개선과 항산화 효과

Anti-amnesic and Antioxidant Effect of Yeongkyekamjotanggayonggolmoryo Aqueous Extracts on Scopolamine-induced Memory Impairment in Mice

3

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives: The purpose of this in vivo study is to observe anti-amnesic effects of Yeongkyekamjotang-gayonggolmoryo (YGYM), a novel mixed herbal prescription, Ossis Mastodi and Ostreae Testa added Yeongkyekamjo-tang, on scopolamine induced amnesia in C57BL/6 mice through acetylcholine (ACh) and acetylcholinesterase (AChE) activity, Choline acetyltransferase (ChAT) mRNA expression, and anti-oxidant effects. Methods: Six groups, total 20 intact or 100 Sco treated mice were used in this study after one week of acclimatization period. Half the animals were used for passive avoidance task tests and hippo-campus ACh content, AChE activity, and ChAT mRNA expression were measured. The other half was subjected to an underwater maze test and then the cerebral cortex antioxidant defense system was measured.Results: In the passive avoidance experiment, there was significant decrease in residence time in the bright room and in the underwater maze test, escape latency to escape from the esophagus sig-nificantly increased compared with the normal control group. At the final sacrifice, ACh content and ChAT mRNA expression decreased, AChE activity increased, and cerebral cortical MDA increased GSH content, SOD and CAT activity in Sco control mice, as compared to intact vehicle control mice. However, these Sco treatment-related memory loss through AChE activation destroyed the cerebral cortex antioxidant defense system, and was inhibited dose-dependently by 28 days consecutive oral pretreatments of YGYM extracts 500, 250, 125 mg/kg.Conclusions: In the above results, YGYM extract that oral administration of YGYM extracts alleviates the antioxidant defense system, through preservation of ACh mediated by upregulation of ChAT mRNA expression, and increase of AChE inhibition and brain antioxidant defense systems.

Abstract

Objectives: The purpose of this in vivo study is to observe anti-amnesic effects of Yeongkyekamjotang-gayonggolmoryo (YGYM), a novel mixed herbal prescription, Ossis Mastodi and Ostreae Testa added Yeongkyekamjo-tang, on scopolamine induced amnesia in C57BL/6 mice through acetylcholine (ACh) and acetylcholinesterase (AChE) activity, Choline acetyltransferase (ChAT) mRNA expression, and anti-oxidant effects. Methods: Six groups, total 20 intact or 100 Sco treated mice were used in this study after one week of acclimatization period. Half the animals were used for passive avoidance task tests and hippo-campus ACh content, AChE activity, and ChAT mRNA expression were measured. The other half was subjected to an underwater maze test and then the cerebral cortex antioxidant defense system was measured.Results: In the passive avoidance experiment, there was significant decrease in residence time in the bright room and in the underwater maze test, escape latency to escape from the esophagus sig-nificantly increased compared with the normal control group. At the final sacrifice, ACh content and ChAT mRNA expression decreased, AChE activity increased, and cerebral cortical MDA increased GSH content, SOD and CAT activity in Sco control mice, as compared to intact vehicle control mice. However, these Sco treatment-related memory loss through AChE activation destroyed the cerebral cortex antioxidant defense system, and was inhibited dose-dependently by 28 days consecutive oral pretreatments of YGYM extracts 500, 250, 125 mg/kg.Conclusions: In the above results, YGYM extract that oral administration of YGYM extracts alleviates the antioxidant defense system, through preservation of ACh mediated by upregulation of ChAT mRNA expression, and increase of AChE inhibition and brain antioxidant defense systems.

참고문헌 (53)

  1. Chuong NN, "Anti-amnesic effect of alkaloid fraction from Lycopodiella cernua (L.) Pic. Serm. on scopolamine-induced memory impairment in mice", Neurosci Lett, 575, pp.42~46 (2014)[DOI]
  2. Taraschenko OD, "Actions of tacrine and galanthamine on histamine-N-methyl transferase", Methods Find Exp Clin Pharmacol, 27, pp.161~165 (2005)[DOI]
  3. 최원희, "들깨 메탄올 추출물의 acetylcholinesterase 억제활성 및 세포독성 보호효과", 한국식품과학회지, 36(6), pp.1026~1031 (2004), 한국식품과학회
  4. Nordberg A, "Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease", Alzheimer Dis Assoc Disord, 20(2), pp.12~18 (2006)[DOI]
  5. Park SM, "Tacrine, an oral acetylcholinesterase inhibitor, induced hepatic oxidative damage, which was blocked by liquiritigenin through GSK3-beta inhibition", Biol Pharm Bull, 38, pp.184~192 (2015)[DOI]
  6. Watkins PB, "Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease", JAMA, 271, pp.992~998 (1994)[DOI]
  7. Dunn NR, "Adverse effects associated with the use of donepezil in general practice in England", J Psychopharmacol, 14, pp.406~408 (2000)[DOI]
  8. Oh MH, "Screening of Korean herbal medicines used to improve cognitive function for anti-cholinesterase activity", Phytomedicine, 11(6), pp.544~548 (2004)[DOI]
  9. Chae IS, "Sanghanronyeokjeon", pp.62~ (1995), Komoonsa
  10. Rho EJ, "Gufangleiju", pp.200~202 (2011), Publshing Gobang
  11. Ha JH, "In vivo characterization of sedative activities of Fossilia Mastodi OSSIS", Biol Pharm Bull, 29, pp.1414~1417 (2006)[DOI]
  12. Hong MW, "Pharmaceutical investigation of fossil shell Crassostrea gravitesta eoilensis Kim et Noda", Korean J Pharmacog, 4, pp.9~17 (1973)
  13. Yun JH, "Study of boiled extract LMK02 on acute oral toxicity in SD rat and effectiveness on <TEX>$A{\beta}$<", TEX>(1-42)level and <TEX>$\beta$<, PS1dE9 mouse model of Alzheimer disease, 37, Graduate School of Oriental Medicine Won Kwang University
  14. Seo JH, "The Enhancing effect of Herbal Mixture (HT008-1) on Memory and Cognitive Function", pp.2008
  15. Hung TM, "Cholinesterase inhibitory and anti-amnesic activity of alkaloids from Corydalis turtschaninovii", J Ethnopharmacol, 119, pp.74~80 (2008)[DOI]
  16. Morris R, "Developments of a water-maze procedure for studying spatial learning in the rat", J Neurosci Methods, 11, pp.47~60 (1984)[DOI]
  17. Del Rio D, "A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress", Nutr Metab Cardiovasc Dis, 15, pp.316~328 (2005)[DOI]
  18. Lee S, "Sulforaphane alleviates scopolamine-induced memory impairment in mice", Pharmacol Res, 85, pp.23~32 (2014)[DOI]
  19. Jamall IS, "Effects of cadmium on glutathione peroxidase, superoxidase dismutase and lipid peroxidation in the rat heart: a possible mechanism of cadmium cardiotoxicity", Toxicol Appl Pharmacol, 80, pp.33~42 (1985)[DOI]
  20. Lowry OH, "Protein measurement with the Folin phenol reagent", J Biol Chem, 193, pp.265~275 (1951)
  21. Sedlak J, "Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent", Anal Biochem, 25, pp.192~205 (1968)[DOI]
  22. Aebi H, "Methods in Enzymatic Analysis", pp.673~686 (1974), Academic Press
  23. Sun Y, "A simple method for clinical assay of superoxide dismutase", Clin Chem, 34, pp.497~500 (1988)
  24. Levene A, "Pathological factors influencing excision of tumours in the head and neck. Part I", Clin Otolaryngol Allied Sci, 6, pp.145~151 (1981)[DOI]
  25. Ludbrook J, "Update: microcomputer statistics packages. A personal view", Clin Exp Pharmacol Physiol, 24 (1997)
  26. Kang SJ, "Fermentation with Aquilariae Lignum enhances the anti-diabetic activity of green tea in type II diabetic db", db mouse, 2014, pp.6, 3536~3571
  27. Hwang EW, "Oriental Medicine Psychiatry", pp.135~ (1989), Hyundae Medical Books
  28. Davies P, "Selective loss of central cholinergic neurons in Alzheimer's disease", Lancet, 2, pp.1403~ (1976)
  29. Giacobini E, "Present progress and future development in the therapy for Alzheimer's disease", pp.1122~ (1989)
  30. Giacobini E, "The cholinergic system in Alzheimer disease", Prog Brain Res, 84, pp.321~332 (1990)
  31. Bachurin SO, "Medicinalchemistry approaches for the treatment and prevention of Alzheimer's disease", Med Res Rev (2003)
  32. Nam Y, "Ameliorating effects of constituents from Cortex Acanthopanacis Radicis on memory impairment in mice induced by scopolamine", J Tradit Chin Med, 34, pp.57~62 (2014)[DOI]
  33. Lee JH, "Yaozheng", pp.228~ (2006), Cheonghong
  34. 박장호, "憂鬱感을 동반한 갱년기 환자의 심계항진증상에 대한 笭桂甘棗湯 치험 3례", 동의신경정신과학회지, 23(2), pp.67~84 (2012), 대한한방신경정신과학회[DOI]
  35. LeDoux JE, "Emotional memory systems in the brain", Behav Brain Res, 58, pp.69~79 (1993)[DOI]
  36. Blusztajn JK, "Choline and cholinergic neurons", Science, 221, pp.614~620 (1983)[DOI]
  37. Brandon EP, "Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency", J Neurosci, 24, pp.5459~5466 (2004)[DOI]
  38. Mohapel P, "Forebrain acetylcholine regulates adult hippocampal neurogenesis and learning", Neurobiol Aging, 26, pp.939~946 (2005)[DOI]
  39. Eichenbaum H, "How does the brain organize memories?", Science, 277, pp.330~332 (1997)[DOI]
  40. Giacobini E, "Cholinesterase inhibitors: new roles and therapeutic alternatives", Pharmacol Res, 50, pp.433~440 (2004)[DOI]
  41. Oda Y, "Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system", Pathol Int, 49, pp.921~937 (1999)[DOI]
  42. Zambrzycka A, "Effects of aging and amyloid-beta peptides on choline acetyltransferase activity in rat brain", Neurochem Res, 27, pp.277~281 (2002)[DOI]
  43. Dawson GR, "Pharmacological mechanisms and animal models of cognition", Behav Pharmacol, 3, pp.285~297 (1992)
  44. Wattanathorn J, "Ingkaninan K. Zingiber officinale mitigates brain damage and improves memory impairment in focal cerebral ischemic rat", Evid Based Complement Alternat Med, 2011, pp.429~505 (2011)
  45. Rao KS, "Free radical induced oxidative damage to DNA: relation to brain aging and neurological disorders", Indian J Biochem Biophys, 46, pp.9~15 (2009)
  46. Ghumatkar PJ, "Nootropic, neuroprotective and neurotrophic effects of phloretin in scopolamine induced amnesia in mice", Pharmacol Biochem Behav, 135, pp.182~191 (2015)[DOI]
  47. Kumar H, "Cognitive enhancing effects of alpha asarone in amnesic mice by influencing cholinergic and antioxidant defense mechanisms", Biosci Biotechnol Biochem, 76, pp.1518~1522 (2012)[DOI]
  48. Mattson MP, "Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases", Ann N Y Acad Sci, 893, pp.154~175 (1999)[DOI]
  49. Nam Y, "Ameliorating effects of constituents from Cortex Acanthopanacis Radicis on memory impairment in mice induced by scopolamine", J Tradit Chin Med, 34, pp.57~62 (2014)[DOI]
  50. Raichle ME, "The pathophysiology of brain ischemia", Ann Neurol, 13, pp.2~10 (1983)[DOI]
  51. Odabasoglu F, "Gastroprotective and antioxidant effects of usnic acid on indomethacin-induced gastric ulcer in rats", J Ethnopharmacol, 103, pp.59~65 (2006)[DOI]
  52. Zhan C, "Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats", Pharmacol Res, 53, pp.303~309 (2006)[DOI]
  53. Hu D, "Schizandrin, an antioxidant lignin from Schisandra chinensis, ameliorates <TEX>$A{\beta}1$<", TEX>-42-induced memory impairment in mice, 2012, pp.2012, 721~

관련 논문AI추천

이 간행물의 다른 논문 (5건)